CERE - Cerevel Therapeutics Net Sales Margin

cerevel.com (CERE) - corporate logo

Cerevel Therapeutics (CERE) brings together top neurobiologists to develop revolutionary treatments for Parkinson's disease. The business's net margin efficiency confirms the issuer's financial stability, where 0.00 determines the current value of the metric. Prospects rely on the success of schizophrenia and Alzheimer's therapies, while independence from macroeconomic factors transforms the company into a reliable defensive asset with a constant influx of investment.

Cerevel Corp (CERE) Net Profit Rate: for the period 07/04/2022 - 08/10/2024

Analytical breakdowns for Cerevel (CERE)

Comprehensive company analysis:cerevel.com, CERE
Manufactured product of Cerevel Therapeutics Inc

Sales margin is defined as the ratio of net profit to total revenue. This indicator captures the portion of funds remaining at the disposal of Cerevel Therapeutics (CERE) after covering all operating and financial expenses. The robotization of laboratory research minimizes personnel costs, directly impacting final profitability. An analysis of current net sales profitability allows for an assessment of the efficiency of this technological model, while low values may signal the risk of a "value trap."

Competitor analysis

BIIB: Net Sales Margin|Net Margin Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Net Sales Margin|AXSM: Net Profit Rate|Net Margin acadia-pharm.com (ACAD)|Net Sales Margin Xenon Pharmaceuticals (XENE)|Net Margin Viking Therapeutics VKTX|Net Profit Rate SUPN|CPRX - Net Margin|Net Margin Denali Therapeutics|HRMY: Net Sales Margin|Biohaven - Net Profit Rate|Return on Sales by Net Profit AMLX|Trevi Therapeutics, Inc. (TRVI) - Company Sales Margin|Return on Sales by Net Profit PRAX (Praxis Medicines)|Anavex Corp - Net Return on Sales|Net Margin CeriBell CBLL|Company Sales Margin Prothena Biosciences (PRTA)|ALEC: Return on Sales by Net Profit|ANNX - Net Sales Margin|Omeros Corp. (OMER) - Net Margin|Net Margin Neurogene Inc. (NGNE)|Return on Sales by Net Profit ACIU|Net Margin VYGR|Net Margin Neumora (NMRA)|SCLX - Net Margin|Net Sales Margin TVGN (Tevogen Bio Holdings Inc.)|Net Profit Rate ACOG|Cognition Therapeutics Inc. - Net Sales Margin|IKT - Net Sales Margin|SAVA: Net Sales Margin|Assertio Holdings, Inc. - Net Profit Rate|COYA (Coya) - Net Sales Margin|Net Return on Sales VTGN (Vistagen Therapeutics)|Net Margin Ovid Rx (OVID)|Acumen Pharmaceuticals - Net Return on Sales|Net Margin CervoMed, Inc. CRVO|Net Sales Margin Alterity Therapeutics ATHE|CLNN: Return on Sales by Net Profit|PEPG (pepgen.com) - Net Return on Sales|Jupiter Neurosciences Inc (JUNS) - Net Margin|Relmada Therapeutics - Net Profit Rate|ANVS (Annovis Bio Inc) - Net Sales Margin|GRCE: Net Profit Rate|Net Margin Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Net Profit Rate|Net Margin neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Net Margin|MTVA: Return on Sales by Net Profit|NeurAxis, Inc (NRXS) - Return on Sales by Net Profit|HSDT: Net Sales Margin|PASG - Company Sales Margin|Net Margin Neuphoria Therapeutics, Inc.|Net Margin NERV|Net Sales Margin ATHA|ADXN (Addex Therapeutics Ltd) - Net Profit Rate|Net Margin alzamend.com ALZN|Company Sales Margin Cyclerion Therapeutics (CYCN)|Protagenic - Net Sales Margin|Net Profit Rate KTTA (Pasithea Therapeutics Corp)|CRGT: Net Sales Margin|Avenue Therapeutics Inc. (ATXI) - Net Sales Margin|BCLI (BrainStorm Cell Therapeutics Inc.) - Net Sales Margin|Net Sales Margin Cara Therapeutics Inc|Net Margin Chromocell Therapeutics (CHRO)|Company Net Profitability ELYM|Net Margin Intra-Cellular ITCI|LBPH: Net Return on Sales|MRNS - Net Margin|NKGen Biotech, Inc. (NKGN) - Return on Sales by Net Profit|neurobopharma.com (NRBO) - Net Margin|SAGE: Company Net Profitability|Net Margin Synaptogenix, Inc.|Net Margin TRVN|Net Sales Margin VIGL|Net Sales Margin anewmeds.com (WENA)